Novel nonviral bioassays for mouse type I and Type III interferon

Journal of Interferon and Cytokine Research

Volumn 31, Issue 4, 2011, Pages 345-349

  Kugel, Daniela ^a   Pulverer, Julia Elisabeth ^b   Köster, Mario ^b   Hauser, Hansjörg ^b   Staeheli, Peter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON A; BETA INTERFERON; FIREFLY LUCIFERASE; GAMMA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERFERON TYPE 1; INTERFERON TYPE 3; INTERLEUKIN 29; LAMBDA INTERFERON 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SENSITIVITY AND SPECIFICITY; TRANSGENIC MOUSE;

ANIMALS; BIOLOGICAL ASSAY; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERONS; MICE; MICE, TRANSGENIC; SENSITIVITY AND SPECIFICITY;

MUS; MUS MUSCULUS;

EID: 79953247569     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0079     Document Type: Article

References (25)

1. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180(4):2474-2485.
2. Ank N, Paludan SR. 2009. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 35(1):82-87.
3. Balkwill FR, Griffin DB, Band HA, Beverley PC. 1983. Immune human lymphocytes produce an acid-labile alpha-interferon. J Exp Med 157(3):1059-1063. (Pubitemid 13117082)
4. Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O. 2001. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75(3):1371-1377. (Pubitemid 32094695)
5. Canosi U, Mascia M, Gazza L, Serlupi-Crescenzi O, Donini S, Antonetti F, Galli G. 1996. A highly precise reporter gene bioassay for type I interferon. J Immunol Methods 199(1):69-76. (Pubitemid 26392329)
6. Chi B, Dickensheets HL, Spann KM, Alston MA, Luongo C, Dumoutier L, Huang J, Renauld JC, Kotenko SV, Roederer M, Beeler JA, Donnelly RP, Collins PL, Rabin RL. 2006. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol 80(10): 5032-5040.
7. Dellgren C, Gad HH, Hamming OJ, Melchjorsen J, Hartmann R. 2009. Human interferon-lambda3 is a potent member of the type III interferon family. Genes Immun 10(2):125-131.
8. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC. 2004. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem 279(31):32269-32274. (Pubitemid 39014676)
9. Francois C, Bernard I, Castelain S, Charleston B, Fray MD, Capiod JC, Duverlie G. 2005. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. Antimicrob Agents Chemother 49(9):3770-3775. (Pubitemid 41233030)
10. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R. 2009. Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem 284(31):20869-20875.
11. Haller O, Kochs G, Weber F. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344(1):119-130. (Pubitemid 41814456)
12. Haller O, Kochs G, Weber F. 2007. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 18(5-6): 425-433. (Pubitemid 47302821)
13. Haller O, Staeheli P, Kochs G. 2009. Protective role of interferon-induced Mx GTPases against influenza viruses. Rev Sci Tech 28(1):219-231.
14. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, Summerfield A, Pavlovic J, Stech J, Staeheli P. 2007. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 88(Pt 5): 1403-1409. (Pubitemid 46723219)
15. Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P. 2007. Protective role of beta interferon in host defense against influenza A virus. J Virol 81(4):2025-2030. (Pubitemid 46214473)
16. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4(1):69-77. (Pubitemid 36109115)
17. Levy-Koenig RE, Golgher RR, Paucker K. 1970. Immunology of interferons. II. Heterospecific activities of human interferons and their neutralization by antibody. J Immunol 104(4):791-797.
18. Lienenklaus S, Cornitescu M, Zietara N, Lyszkiewicz M, Gekara N, Jablonska J, Edenhofer F, Rajewsky K, Bruder D, Hafner M, Staeheli P, Weiss S. 2009. Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol 183(5):3229-3236.
19. Meager A. 2002. Biological assays for interferons. J Immunol Methods 261(1-2):21-36. (Pubitemid 34175214)
20. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4(9):e1000151.
21. Pestka S. 1986. Interferon standards and general abbreviations. Methods Enzymol 119:14-23. (Pubitemid 16025087)
22. Pulverer JE, Rand U, Lienenklaus S, Kugel D, Zietara N, Kochs G, Naumann R, Weiss S, Staeheli P, Hauser H, Koster M. 2010. Temporal and spatial resolution of type I and III IFN responses in vivo. J Virol 84(17):8626-8638.
23. Schwarz H, Harlin O, Ohnemus A, Kaspers B, Staeheli P. 2004. Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J Interferon Cytokine Res 24(3):179-184.
24. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4(3): e1000017.
25. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. 2007. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen- activated protein kinases. J Virol 81(14):7749-7758. (Pubitemid 47047861)